Clinical Trials Logo

Clinical Trial Summary

This is the clinical registry of cell based therapies that is available to researchers around the world. The registry is web based. All researches must provide IRB approval to the coordinating site- University of Utah in order to obtain access to the registry. The are predetermined case report forms for cardiovascular diseases that are currently in clinical trials- including demographics, safety, and possible efficacy end-points. All investigators have access to their own data. The servers are U.S. HIPPA compliant and protected with secure back-up.


Clinical Trial Description

The clinical cell registry includes data on thoracic and cardiovascular diseases including:

Acute myocardial infarction, Chronic Angina, Heart Failure, Wound Healing including Sternal, Peripheral Arterial Disease, Critical Limb Ischemia, Type 2 Diabetes, COPD, Asthma. Neurological disorders registry is available to specifics sites if requested. Our own biological data at the University of Utah including co-localized data with Society of Thoracic Surgeons also is a part of this program. Cell based therapies that are autologous and allogeneic are included in the registry ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00130377
Study type Interventional
Source Amit, Patel N, M.D.
Contact Amit N. Patel, MD, MS
Email amit.patel@hsc.utah.edu
Status Recruiting
Phase Phase 2/Phase 3
Start date August 2002
Completion date December 2020